Sign In
NewsRadar

Apogenix

Apogenix develops drugs based on the targeted modulation of apoptosis (programmed cell death). Apoptosis is a natural and highly controlled mechanism to clear the body of old, damaged or abnormally transformed cells. In many disease indications, this process has become out of balance causing either an uncontrolled removal of healthy cells and tissue or a lack of removal of damaged and abnormal cells. Apogenix is a spin-out from the German Cancer Research Center (DKFZ).

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Im Neuenheimer Feld 584
Heidelberg 69120
Germany
+49-(0)6221-58608-0
+49-(0)6221-58608-10
http://www.apogenix.com
Thomas Höger
+49-(0)6221-58608-0

Company Facts
Founded:Jul 2005
Founders:
CEO:Thomas Höger
CTO or technical lead:Harald Fricke
CFO or finance director:Thomas Höger
Head of Sales:
Head of Marketing:

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:22
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


26,129
Tech investments
From our Online Data Service
16,883
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Sep 13N/AEnergy related
Sep 13€12.6MConsumer electronics
Sep 12€39.0MBiopharmaceuticals
Sep 12N/AKnowledge management
Sep 12€2.3MInternet commerce
Sep 12€2.1MInternet services
Sep 12€4.0MMedical devices

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.